Premium Information is available for this item - Upgrade for $1 a day
6540-01-571-2686
Spectacle Case
6540015712686 015712686 07-015
INC: 01833 Spectacle Case
January 2023
4

Marketplace 6540-01-571-2686
Request a Quotation from participating marketplace vendors
Related Documents 6540-01-571-2686 1+ Documents (More...)
Spectacle Case 6540015712686 015712686,07-015 6540-01-571-2686 1+ Documents ( More... ) https//www.nsnlookup.com
/fsg-65/fsc-6540/us 6540-01-571-2686 Spectacle Case 6540015712686 015712686,07-015 6540-01-571-2686
Restrictions 6540-01-571-2686
6540-01-571-2686 is a Spectacle Case that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item is not suspected to be hazardous. This item does not contain a precious metal.
Import and Export 6540-01-571-2686
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6540-01-571-2686
- Canada (ZC01)
- Effective Date:
- 1 Feb 2015
- Denmark (ZS01)
- Effective Date:
- 1 Jan 2009
Approved Sources 6540-01-571-2686
- Part Number
- Manufacturer
- Status
- 07-015
- Manufacturer
- 0PZV4 - Oakley Inc (Active)
- Primary Buy
- Primary Buy
Datasheet 6540-01-571-2686
- Characteristic
- Specifications
- FIIG
- Specifications
- T146-C
- Material [MATT]
- Plastic Polyvinyl Chloride
- Lining Material [AJNY]
- Plastic
- Special Features [FEAT]
- M-Frame Array Case; Black, Semi-Rigid Nylon/Foam Liner; Holds Up To 3 Lens
Similar Supply Items to 6540-01-571-2686


















Freight Information 6540-01-571-2686
6540-01-571-2686 has freight characteristics.. 6540-01-571-2686 has a variance between NMFC and UFC when transported by rail and the description should be consulted.